Authored By: Muskan
Maharshi Dayanand University
Introduction
This case lies at the intersection of constitutional law, medical jurisprudence, and end-of-life decision-making, primarily dealing with the legality of withdrawing life-sustaining treatment. It builds upon and operationalises the principles laid down in Common Cause (2018) regarding the right to die with dignity under Article 21. The case is significant as it addresses practical gaps in implementing passive euthanasia guidelines, especially in situations involving long-term home-based care. It is noteworthy for clarifying that Clinically Assisted Nutrition and Hydration (CANH) constitutes medical treatment and can be withdrawn under appropriate safeguards. The judgment also refines the “best interest of the patient” standard and strengthens procedural mechanisms, making it an important step in evolving India’s legal framework on dignity, autonomy, and end-of-life care.
Facts of the Case
The case concerns Harish Rana, a 32-year-old man, represented through his parents, who have been his primary caregivers since a life-altering accident. In 2013, while pursuing his B.Tech, he fell from the fourth floor of his accommodation, suffering a severe diffuse axonal brain injury. Despite immediate and continued medical intervention, his condition deteriorated into a Permanent Vegetative State (PVS), marked by complete dependence, lack of awareness, and inability to communicate.
Over the years, he required continuous medical support, including tracheostomy for breathing and Clinically Assisted Nutrition and Hydration (CANH) through a PEG tube for sustenance. Medical reports consistently indicated irreversible brain damage, no cognitive function, and negligible chances of recovery. Despite extensive treatments and therapies for over 13 years, his condition remained static, with recurring infections and complications such as bedsores.
His family, having provided long-term care, observed no improvement and believed that the continuation of artificial life support only prolonged his suffering. They asserted that he had no meaningful interaction with his surroundings and was entirely dependent on medical intervention for survival.
In light of his irreversible condition, the family sought a determination on whether continued medical treatment—particularly CANH—should be withdrawn in his best interest. Medical evaluation boards, constituted to assess his condition, unanimously concluded that he remained in a permanent vegetative state with no possibility of recovery, and that continued treatment served only to sustain biological existence without therapeutic benefit.
The central factual issue thus arose from the conflict between prolonging life through artificial medical support and ensuring a dignified existence, as the patient was incapable of expressing his own will, leaving the decision to be guided by medical opinion and the family’s assessment of his best interests.
Legal Issues
Issue 1: Whether Clinically Assisted Nutrition and Hydration (CANH) administered through a PEG tube constitutes “medical treatment” within the meaning of the law governing withdrawal or withholding of life-sustaining treatment?
Issue 2: Whether, in the absence of an Advance Medical Directive (AMD), the withdrawal or withholding of life-sustaining treatment from a patient in a Permanent Vegetative State (PVS) is permissible under Article 21 of the Constitution of India?
Issue 3: What is the scope and application of the “best interest of the patient” principle in determining whether continued medical treatment should be prolonged or withdrawn?
Issue 4: Whether, in the facts of the present case, it is in the best interest of the patient to continue life-sustaining treatment or to allow withdrawal in order to uphold the right to die with dignity?
Arguments Presented
Petitioner’s Arguments (Harish Rana through his parents)
The case is governed by the principles laid down in Common Cause (2018), recognising the right to die with dignity under Article 21.
CANH (Clinically Assisted Nutrition and Hydration) administered through a PEG tube is medical treatment, not mere basic care, and can be withdrawn.
The patient has been in an irreversible Permanent Vegetative State (PVS) for over 13 years with no possibility of recovery, as confirmed by medical reports.
The core issue is whether it is in the patient’s best interest to continue artificial life support, not whether he should die.
Continued treatment is futile and only prolongs biological existence, without improving quality of life.
Reliance placed on Common Cause (2018) and its 2023 clarification, which permit withdrawal of life support including feeding tubes.
Forcing continuation of treatment violates dignity, autonomy, and bodily integrity under Article 21.
Highlighted gaps in implementation of guidelines, especially in home-care settings, and requested procedural clarity.
Respondent’s Arguments (Union of India)
Accepted that passive euthanasia is legally permissible where treatment is futile, as per Common Cause (2018).
Argued that CANH through medical devices constitutes medical treatment, relying on judicial precedents and comparative jurisprudence.
Withdrawal of such treatment does not amount to causing death, but allows death due to the underlying medical condition.
Medical board reports clearly establish that the patient’s condition is irreversible with no hope of recovery.
Continued treatment lacks therapeutic benefit and serves only to prolong suffering.
The family’s decision is informed, voluntary, and based on long-term caregiving experience.
Supported withdrawal of treatment in line with the “best interest of the patient” principle.
Requested that palliative care and humane support be ensured to maintain dignity during the end-of-life process.
Court’s Reasoning and Analysis
The Court grounded its reasoning in the constitutional framework of Article 21, particularly the jurisprudence developed in Common Cause (2018), which recognises the right to die with dignity as an intrinsic part of the right to life. It began by clarifying the legal distinction between active and passive euthanasia, emphasizing that while active euthanasia involves a positive act to cause death and remains impermissible, passive euthanasia—withdrawal or withholding of medical treatment—is legally permissible as it allows the underlying disease to take its natural course.
On the first issue, the Court interpreted Clinically Assisted Nutrition and Hydration (CANH) as medical treatment, not merely basic care. It reasoned that when nutrition and hydration are administered through medical devices such as PEG tubes, they become part of an artificial medical regime sustaining life. Relying on Common Cause (2018) and comparative jurisprudence like Airedale NHS Trust v. Bland, the Court concluded that withdrawal of CANH falls within the scope of permissible passive euthanasia.
On the second and third issues, the Court elaborated the “best interest of the patient” principle. It held that this standard is not confined to medical factors alone but includes non-medical considerations such as dignity, quality of life, and the patient’s condition as understood by caregivers. The Court examined global practices (USA, UK, etc.) and concluded that where a patient is in an irreversible PVS with no hope of recovery, continued treatment that merely prolongs biological existence without cognitive function may not serve the patient’s best interests.
Applying these principles to the present case, the Court relied heavily on the findings of the primary and secondary medical boards, both of which confirmed that the applicant’s condition was irreversible and that continued treatment had no therapeutic benefit. The Court accepted the petitioner’s argument that the real question was not whether to end life, but whether to continue futile treatment. It also gave weight to the informed and consistent decision of the family, who had cared for the patient for over a decade and sought withdrawal of treatment to preserve his dignity.
Thus, the Court’s reasoning progressed from constitutional principles to medical facts, ultimately concluding that withdrawal of CANH, in this case, would be legally permissible and consistent with the patient’s best interests and dignity.
Judgment and Ratio Decidendi
The Decision:
The Court held that Clinically Assisted Nutrition and Hydration (CANH) administered through a PEG tube constitutes medical treatment.
It ruled that withdrawal or withholding of such treatment is legally permissible under the framework of passive euthanasia recognised in Common Cause (2018).
The Court found that the applicant was in an irreversible Permanent Vegetative State (PVS) with no possibility of recovery, based on medical board reports.
It held that continuation of life-sustaining treatment was not in the best interest of the patient, as it only prolonged biological existence without dignity or therapeutic benefit.
Accordingly, the Court permitted withdrawal of CANH, allowing the patient to die naturally from the underlying condition.
The Court directed that the process must be carried out in accordance with safeguards and procedural guidelines, ensuring medical supervision.
It further directed that palliative care and end-of-life (EOL) care be provided to ensure dignity and comfort during the process.
The Court also issued broader directions to streamline and clarify the implementation of Common Cause guidelines, especially in cases involving home-based care.
Ratio Decidendi:
Withdrawal or withholding of life-sustaining treatment, including CANH administered through medical devices, is permissible under Article 21 when the patient is in an irreversible condition and such treatment is not in their best interest.
The right to die with dignity includes the right to refuse or discontinue futile medical treatment, provided the decision is taken in accordance with established safeguards and the “best interest of the patient” principle.
Significance of the Decision
This judgment makes a substantial contribution to Indian constitutional and medical jurisprudence by clarifying and operationalising the principles laid down in Common Cause (2018). While Common Cause recognised passive euthanasia in theory, this case bridges the gap between doctrine and practice, particularly in non-hospital, home-care settings. The Court decisively settles the ambiguity regarding whether CANH constitutes medical treatment, thereby resolving a previously uncertain legal issue. Additionally, by elaborating the “best interest of the patient” standard through both medical and non-medical considerations, the judgment aligns Indian law with international jurisprudence, especially from the UK and other common law jurisdictions.
Implications and Impact
The ruling has far-reaching implications for patients in irreversible conditions, their families, and medical practitioners. It provides legal clarity and reassurance to doctors, reducing the fear of liability when withdrawing futile treatment in accordance with guidelines. For families, it recognises their role in decision-making where the patient is incapable, thereby humanising end-of-life care.
Critical Evaluation
A key strength of the judgment lies in its balanced constitutional reasoning, harmonising the sanctity of life with the right to dignity. The Court’s reliance on medical evidence and structured guidelines ensures that the decision is not arbitrary but grounded in objective assessment. Its recognition of dignity as central to Article 21 reflects a progressive and humane approach.
However, certain limitations remain. The judgment continues to rely heavily on judicial guidelines rather than a clear legislative framework, which may lead to inconsistent application across states. The “best interest” standard, though elaborated, retains a degree of subjectivity, potentially leading to varied interpretations by medical boards. Additionally, while the Court emphasises family consent, it does not fully address situations of family conflict or misuse, leaving a grey area in safeguarding patient interests.
An alternative approach could have been to lay down more concrete procedural safeguards or timelines, or to push more strongly for immediate legislative intervention. Nonetheless, the decision stands as a progressive yet cautious step, advancing the law while acknowledging the need for further institutional development.
Conclusion
This case marks a crucial development in Indian constitutional law by applying and strengthening the principles of passive euthanasia established in Common Cause (2018). The Court carefully examined the patient’s irreversible condition, the nature of CANH as medical treatment, and the “best interest” principle, ultimately permitting withdrawal of life-sustaining treatment to uphold dignity under Article 21.
The key takeaway from this judgment is that the right to life includes the right to die with dignity, which extends to refusing or discontinuing futile medical treatment in appropriate cases.
This judgment will be remembered for bridging the gap between legal theory and medical practice, particularly by clarifying that CANH can be withdrawn and by addressing procedural challenges in real-life situations. However, it also highlights the absence of a comprehensive statutory framework, leaving room for future legislative action. The case opens the door for further evolution of end-of-life jurisprudence, especially regarding clearer safeguards and uniform implementation across India.
Reference(S) (Bluebook 20th Edition)
Harish Rana v. Union of India & Ors., 2026 INSC 222 (India).
Common Cause (A Regd. Soc’y) v. Union of India, (2018) 5 S.C.C. 1 (India).
Common Cause v. Union of India, (2023) 14 S.C.C. 131 (India).
Aruna Ramachandra Shanbaug v. Union of India, (2011) 4 S.C.C. 454 (India).
Gian Kaur v. State of Punjab, (1996) 2 S.C.C. 648 (India).
Airedale NHS Tr. v. Bland, [1993] A.C. 789 (H.L.) (U.K.).
Vacco v. Quill, 521 U.S. 793 (1997).
Rodriguez v. British Columbia (Att’y Gen.), [1993] 3 S.C.R. 519 (Can.).
Law Comm’n of India, 196th Report: Medical Treatment to Terminally Ill Patients (Protection of Patients and Medical Practitioners) (2006).
Law Comm’n of India, 241st Report: Passive Euthanasia—A Relook (2012).
